Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Change in Accured Expenses: 2020-2024

Historic Change in Accured Expenses for Pyxis Oncology (PYXS) over the last 5 years, with Dec 2024 value amounting to -$1.7 million.

  • Pyxis Oncology's Change in Accured Expenses fell 67.29% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.1 million, marking a year-over-year change of. This contributed to the annual value of -$1.7 million for FY2024, which is 88.15% up from last year.
  • Latest data reveals that Pyxis Oncology reported Change in Accured Expenses of -$1.7 million as of FY2024, which was up 88.15% from -$14.1 million recorded in FY2023.
  • Pyxis Oncology's 5-year Change in Accured Expenses high stood at $12.0 million for FY2022, and its period low was -$14.1 million during FY2023.
  • For the 3-year period, Pyxis Oncology's Change in Accured Expenses averaged around -$1.3 million, with its median value being -$1.7 million (2024).
  • Per our database at Business Quant, Pyxis Oncology's Change in Accured Expenses skyrocketed by 192.31% in 2021 and then tumbled by 217.96% in 2023.
  • Pyxis Oncology's Change in Accured Expenses (Yearly) stood at $1.7 million in 2020, then skyrocketed by 192.31% to $5.1 million in 2021, then soared by 134.70% to $12.0 million in 2022, then plummeted by 217.96% to -$14.1 million in 2023, then spiked by 88.15% to -$1.7 million in 2024.